Xilio Therapeutics Inc (XLO)

Xilio Therapeutics Inc Azioni (XLO) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	13.70% 17.36	20.12	23.53	23.17	20.21
Operating Income/Loss	13.70% -17.36	-20.12	-23.53	-23.17	-20.21
Nonoperating Income/Loss	19.45% 0.613	0.761	0.88	0.701	0.416
Income/Loss From Continuing Operations Before Tax	13.47% -16.75	-19.36	-22.65	-22.47	-19.79
Income/Loss From Continuing Operations After Tax	13.47% -16.75	-19.36	-22.65	-22.47	-19.79
Net Income/Loss	13.47% -16.75	-19.36	-22.65	-22.47	-19.79
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.20% 27.52	27.47	27.43	0.008	27.40
Basic Earnings Per Share	12.86% -0.61	-0.70	-0.83	-0.82	-0.72
Diluted Earnings Per Share	12.86% -0.61	-0.70	-0.83	-0.82	-0.72
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-